الفهرس | Only 14 pages are availabe for public view |
Abstract Using standard needles, endoscopic ultrasound-guided fineneedle aspiration (EUS-FNA) has a high diagnostic value in evaluating solid lesions. The endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) was designed to enhance the quality of EUS-guided tissue sampling by providing core biopsies. We conduct this study to compare the diagnostic yield and accuracy of the 22-G FNA needle with the 20G, 22G, or 25G procore needles in sampling pancreatic and other intra-abdominal lesions. Material and methods: This prospective study included 100 cases presented either with pancreatic or non-pancreatic and referred to Kasr Al Aini hospital, internal medicine department, from May 2018 to March 2021. Patients were randomly assigned to one of two groups: EUS-FNA (n = 50) or EUS-FNB (n = 50). The primary objectives were to compare the diagnostic yield and the median number of passes necessary to retrieve core tissue using EUS-FNA and EUS-FNB needles. Results: The study involved 100 patients, 57 males and 43 females, with a mean age of 58±15 years (range: 26–81 years). No significant difference was detected between EUS-FNA and EUS-FNB regarding safety, diagnostic accuracy, or the median number of needle passes. However, FNB needles outperformed FNA in histologic yield (98% vs 88%, P = 0.001). Tissue blood contamination was significantly higher in cell blocks of the FNA group. Conclusion: EUS-guided FNA and FNB have comparable diagnostic accuracy for pancreatic and non-pancreatic lesions. However, FNB improved the histopathologic quality of samples, facilitating immunohistochemistry and molecular studies needed for individualized therapy. |